Depemokimab Cuts Exacerbation Rate in Eosinophilic Asthma
Annualized rate of exacerbations reduced across two randomized trials in severe asthma with eosinophilic phenotype
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.